Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu
    [{"orgOrder":0,"company":"Nortec Quimica","sponsor":"The Medicines Patent Pool","pharmaFlowCategory":"D","amount":"Undisclosed","upfrontCash":"Undisclosed","newsHeadline":"Nortec Qu\u00edmica Receives License From The Medicines Patent Pool (MPP) to Produce API Nirmatrelvir for Innovative Oral Treatment Against Covid-19","therapeuticArea":"Infections and Infectious Diseases","highestDevelopmentStatus":"Phase II\/ Phase III","country":"BRAZIL","productType":"Small molecule","productStatus":"Approved","date":"March 2022","url1":"","url2":"","graph1":"Infections and Infectious Diseases","graph2":"Phase II\/ Phase III"},{"orgOrder":0,"company":"Nortec Quimica","sponsor":"Fiocruz","pharmaFlowCategory":"D","amount":"Undisclosed","upfrontCash":"Undisclosed","newsHeadline":"Fiocruz and Nortec Quimica Launch Partnership Against Chagas Disease","therapeuticArea":"Infections and Infectious Diseases","highestDevelopmentStatus":"Phase II","country":"BRAZIL","productType":"Small molecule","productStatus":"Approved","date":"May 2023","url1":"","url2":"","graph1":"Infections and Infectious Diseases","graph2":"Phase II"}]

    Find Clinical Drug Pipeline Developments & Deals by Nortec Quimica

    Menu

    Nortec Quimica

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    Key Products KEY PRODUCTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Loading...

    All Data

    Previous
    Next
    Filters Filter
    ×
    FILTER:
    filter Company
      filter Sponsor
        filter Country
          filter Therapeutic Area
            filter Study Phase

              Active Filter(s):

              refreshFilters
              refreshReset Filter
              refresh Reset Filter
              price-trend All Developments

              Companies By Therapeutic Area

              Development Status

              Nortec Quimica

              Contact Supplier
              • Deals
              Virtual BoothNortec Quimica is the largest API manufacturer in Latin America.
              Contact Supplier Contact Supplier
              Flag Brazil
              Virtual Booth Virtual Booth
              Digital Content Digital Content

              Fiocruz and Nortec Quimica Launch Partnership Against Chagas Disease

              Details:

              The partnership aims to improve the production of the active pharmaceutical ingredient (API) of benznidazole, the only drug used in Brazil for the Chagas disease.

              Lead Product(s): Benznidazole

              Therapeutic Area: Infections and Infectious Diseases Product Name: Undisclosed

              Highest Development Status: Phase II Product Type: Small molecule

              Recipient: Fiocruz

              Deal Size: Undisclosed Upfront Cash: Undisclosed

              Deal Type: Partnership May 02, 2023

              Nortec Quimica

              CPhI North America

              Attending

              envelop Contact Supplier

              Nortec Quimica

              Contact Supplier
              • Deals
              Virtual BoothNortec Quimica is the largest API manufacturer in Latin America.
              Contact Supplier Contact Supplier
              Flag Brazil
              Virtual Booth Virtual Booth
              Digital Content Digital Content

              Nortec Química Receives License From The Medicines Patent Pool (MPP) to Produce API Nirmatrelvir for Innovative Oral Treatment Against Covid-19

              Details:

              With this agreement, the active pharmaceutical ingredient nirmatrelvir can be fully manufactured in Brazil by Nortec, ensuring safety and adherence to treatment for countries such as: South Africa, Tanzania, Venezuela, Bolivia, Ethiopia, Haiti, Honduras, among others.

              Lead Product(s): Nirmatrelvir,Ritonavir

              Therapeutic Area: Infections and Infectious Diseases Product Name: Nirmatrelvir-Generic

              Highest Development Status: Phase II/ Phase III Product Type: Small molecule

              Partner/Sponsor/Collaborator: The Medicines Patent Pool

              Deal Size: Undisclosed Upfront Cash: Undisclosed

              Deal Type: Licensing Agreement March 22, 2022

              Nortec Quimica

              CPhI North America

              Attending

              envelop Contact Supplier

              Nortec Quimica
              Send me more info on How To Grow My Business Digitally?
              Post Enquiry
              POST ENQUIRY